ASPH R&D

Research & Development Department for Ashford & St Peter's Hospitals NHS Foundation Trust 🌈💙

[ASPH R&D @ASPH_RD]

We are so incredibly proud of @MariaCroft11 who was awarded the Unsung Hero of @ASPHFT 2021! Maria, you have worked relentlessly throughout this pandemic & have blessed our patients with your courageous compassion & have inspired our team with your hopeful spirit! Thank you! 💗

[ASPH R&D @ASPH_RD]

Its such a pleasure to see one of our long covid research patients going home 🥰

[Sharon Simpson @SharonS85118833]

Trish has given me permission to tweet this video, after a very tough month and an emotional tiring battle with Covid this lady was discharged from #ASPH Aspen ward on Thursday, every member of our team has helped her to overcome this dreadful virus. Well done to everyone 🙂🥳👏

[ASPH R&D @ASPH_RD]

@NourishOurNurse @ASPHFT @AndyField1 Its amazing to continue seeing such generosity from our community. After many cracked hands and hearts that all front line health care workers have endured, its the small things that keep us going 💙

[ASPH R&D @ASPH_RD]

Proud to be part of a new discovery to help the patients in the community. If you would like to help us with this trial and you have had a positive test within 48 hours, aged between 18-70 with mild symptoms please get in touch by calling 01932723534. Thankyou @ASPHFT

[Sam Holder @samholdertv]

"A game-changer" according to scientists involved.

Trials are starting on a nasal spray which could be 99.9% effective at killing coronavirus.

Virologists at @ASPHFT think it could potentially treat people up to 4 days after infection.

Exclusive access for @itvlondon.

[ASPH R&D @ASPH_RD]

A huge thanks to all the staff at @ASPHFT for helping us with this trial. An even bigger thanks to all patients who donated their plasma and to those who kindly volunteered to trial it while admitted to hospital. We have discovered a very important question in scientific history.

[National Institute for Health and Care Research @NIHRresearch]

BREAKING: The RECOVERY trial finds no overall benefit for convalescent plasma in moderately ill patients taking part. It has now closed recruitment to this treatment arm for all hospitalised patients. A huge thanks to everyone who took part & donated blood
https://t.co/hQkop1sqja

[ASPH R&D @ASPH_RD]

Fantastic effort from ⁦@AsphCCare⁩ and our lovely Maria Croft for their work on the GENOMICC study. A massive thank you to all the patients and/or relatives for their consent of a blood sample during their critical care stay. 🙏🏻⁦@ASPHFT⁩ https://t.co/qsOnPBEK39

[ASPH R&D @ASPH_RD]

@AndyField1 @NHSBT @ASPHFT @CSHSurrey Well done Andy, that’s fantastic! 👏🏻

[ASPH R&D @ASPH_RD]

Thrilled to be on board and taking part in this trial! @NIHRCRN_kss @ASPHFT #bepartofresearch

[PARROT-2 Trial @PARROT2_Trial]

So excited to have @ASPH_maternity starting enrolment to #PARROT2 #PlacentalGrowthFactor #PreEclampsia @McdonnellSian @alice_hurrell @JenieSparkes @DrLouiseWebster @LucyChappell2

[Kenneth Baillie @kennethbaillie]

It looks like @GenomiccStudy will reach 5000 critically-ill cases recruited in the next hour. Intensive care units across the country are somehow managing to recruit patients despite extraordinary clinical pressure. 20 from @BHRUT_NHS alone in last 2wks

[ASPH R&D @ASPH_RD]

Pleased to have restarted recruiting to this trial @ASPHFT 👏🏻 #SCAF

[The ARTESiA Trial 🇨🇦 @Artesia_RCT]

We are pleased to announce that @Artesia_RCT has reached an important milestone of the 3,500th patient! A congratulations to Dr. Marta Pombo & Study Staff for enrolling the 3500th patient. @PHRIresearch #SCAF

[ASPH R&D @ASPH_RD]

For the latest news surrounding our DEFEAT trial - follow the trial specific twitter page @CovidTrial 🦠🦠 @ASPHFT @NIHRCRN_kss @AsphCCare @AshStPetersLibs #COVID19

[ASPH R&D @ASPH_RD]

Thrilled to be part of this pioneering COVID-19 trial here at @ASPHFT with already a dozen patients enrolled! 👏🏻👏🏻 @NIHRCRN_kss

[DEFEAT-COVID Trial @CovidTrial]

Welcome to the DEFEAT-COVID clinical trial.

We are trying to establish if leflunomide, used for rheumatoid arthritis, is clinically effective against COVID infection.

We are looking to open new sites; contact [email protected] or [email protected] for info.

[ASPH R&D @ASPH_RD]

Could pave the way to much more in depth research into the body’s response to Covid as well as how well a vaccine were to work if someone was then infected:
UK plan to be first to run human challenge Covid trials ✨ https://t.co/rzgZ37UqGT

[StPetersNICU @StNicu]

48 hours after opening, first baby enrolled on @Feed1Trial 🎉 Great work team! @ASPH_RD

[ASPH R&D @ASPH_RD]

@SurfingEm @kfy98 @BeTheChangeASPH @fiholley @hnbarker Yes please! I think we should make it mandatory 🤪

[Claire Atkinson @clairep1827]

Great to see the latest #COVID19 @NIHRresearch clinical trial being conducted here in @ASPHFT through @ASPH_RD

Thank you to everyone involved, this trial may change the way we test for Covid-19 and maybe other viruses in the future.

#IamResearch #NIHR

https://t.co/5txIDNHs2M

[Susan Hopkins @SMHopkins]

Thank you - all research teams @NHSuk @NHSEngland Trusts & all the staff participants for coming on board to #SIREN @PHE_uk study - 10k participants which will help us understand whether those with antibodies get fewer/ no #COVID19 re-infections - Amazing https://t.co/AM0NpMQeJh

[ASPH R&D @ASPH_RD]

Express your interest in COVID-19 Vaccine trials now! @ASPHFT @NIHRCRN_kss @NIHRtakepart @AsphCCare @ASPHStudentNurs

[Be Part of Research @NIHRtakepart]

In less than 5 minutes you could be part of a national effort to find a vaccine for #Covid19. 💉

Join the register that’s helping researchers to find people willing to #BePartOfResearch and fightback against the virus. #VaccinesWork

Sign up now ➡ https://t.co/EMeXf8RWYg

[ASPH R&D @ASPH_RD]

@alexelindsay Just like all research, stickers can be voluntary too 😇😅 @NIHRtakepart